MCVE News # 2 MacroSolve and MEDL Mobile Sign Dea

MCVE News # 2

7:20a ET March 12, 2013 (Market Wire)

MacroSolve, Inc. (OTCQB: MCVE) ("MacroSolve" or the "Company"), a leading provider of mobile technology intellectual property, announces the finalization of the agreement with MEDL Mobile Holdings, Inc. (OTCBB: MEDL) ("MEDL Mobile") a pioneer in the creation, development, marketing and monetization of mobile apps.

Seeking to provide the benefits of its intellectual property to mobile app developers, MacroSolve has finalized its agreement with MEDL Mobile to bring forth a program that offers access to MacroSolve's U.S. Patent 7,822,816 to thousands of app developers. MEDL Mobile has the right to grant a license of the patent to its clients on a 'per install' basis. MacroSolve will benefit by receiving a percentage of the passive revenues which are subject to MEDL achieving minimum performance goals.

"Our partnership with MacroSolve will now offer substantial intellectual property benefits to emerging app developers," said Andrew Maltin, MEDL Mobile CEO. "We are excited to be able to add to our increasing library of tools and services for our growing Developer Network."

MacroSolve Chairman and CEO Jim McGill states, "MEDL is the first visionary partner to provide the benefits of the '816' patent to thousands of app developers. Our joint agreement is designed to be a simple and affordable solution for app developers."

MacroSolve's U.S. Patent No 7,822,816 addresses mobile information collection system across all wireless networks, smartphones, tablets and rugged mobile devices. The patent, a significant intellectual property asset to MacroSolve, covers fundamental technology in the mobile application space utilized by multiple companies.

About MacroSolve Founded in 1997, MacroSolve is heralded for its robust IP portfolio, while advancing throughout the mobile apps era by innovating key technologies that have laid the foundation for apps and next-gen developers. Today, MacroSolve is empowering a new era of mobile innovators seeking advisory services and IP strength from a source of experience.